CN103396360A - 一种制备磷酸伯胺喹的方法 - Google Patents
一种制备磷酸伯胺喹的方法 Download PDFInfo
- Publication number
- CN103396360A CN103396360A CN2013103760933A CN201310376093A CN103396360A CN 103396360 A CN103396360 A CN 103396360A CN 2013103760933 A CN2013103760933 A CN 2013103760933A CN 201310376093 A CN201310376093 A CN 201310376093A CN 103396360 A CN103396360 A CN 103396360A
- Authority
- CN
- China
- Prior art keywords
- ketone
- reaction
- solvent
- diphosphate
- quinolylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 229960005179 primaquine Drugs 0.000 title claims abstract description 12
- INDBQLZJXZLFIT-UHFFFAOYSA-N primaquine Chemical compound N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 INDBQLZJXZLFIT-UHFFFAOYSA-N 0.000 title 1
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000013067 intermediate product Substances 0.000 claims abstract description 21
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 20
- 150000002466 imines Chemical class 0.000 claims abstract description 17
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 39
- 238000006243 chemical reaction Methods 0.000 claims description 36
- 239000002904 solvent Substances 0.000 claims description 35
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 25
- 239000001177 diphosphate Substances 0.000 claims description 25
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 25
- 235000011180 diphosphates Nutrition 0.000 claims description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000003054 catalyst Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 19
- -1 nitroketone compound Chemical class 0.000 claims description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 17
- 230000001476 alcoholic effect Effects 0.000 claims description 13
- 229960004756 ethanol Drugs 0.000 claims description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000012043 crude product Substances 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 238000001953 recrystallisation Methods 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 4
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000015320 potassium carbonate Nutrition 0.000 claims description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical group CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- GJOHLWZHWQUKAU-UHFFFAOYSA-N 5-azaniumylpentan-2-yl-(6-methoxyquinolin-8-yl)azanium;dihydrogen phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 GJOHLWZHWQUKAU-UHFFFAOYSA-N 0.000 abstract description 11
- 239000000047 product Substances 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000006722 reduction reaction Methods 0.000 abstract description 7
- 238000006482 condensation reaction Methods 0.000 abstract description 6
- 229960005462 primaquine phosphate Drugs 0.000 abstract description 5
- 150000003839 salts Chemical class 0.000 abstract description 2
- YGGTVPCTAKYCSQ-UHFFFAOYSA-N 6-methoxyquinolin-8-amine Chemical compound N1=CC=CC2=CC(OC)=CC(N)=C21 YGGTVPCTAKYCSQ-UHFFFAOYSA-N 0.000 abstract 1
- 150000003141 primary amines Chemical class 0.000 description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000000967 suction filtration Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 239000002223 garnet Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000007867 post-reaction treatment Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- RSOFRZVKSLAHAV-UHFFFAOYSA-N OP(O)(=O)OP(=O)(O)O.N1=CC=CC2=CC=CC=C12 Chemical compound OP(O)(=O)OP(=O)(O)O.N1=CC=CC2=CC=CC=C12 RSOFRZVKSLAHAV-UHFFFAOYSA-N 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 206010035503 Plasmodium vivax infection Diseases 0.000 description 1
- 201000009976 Plasmodium vivax malaria Diseases 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 208000005469 Vivax Malaria Diseases 0.000 description 1
- SNPYETFJDAJETL-UHFFFAOYSA-N [SiH4].BrC(CCC)C Chemical compound [SiH4].BrC(CCC)C SNPYETFJDAJETL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- QTQWMSOQOSJFBV-UHFFFAOYSA-N pamaquine Chemical group C1=CN=C2C(NC(C)CCCN(CC)CC)=CC(OC)=CC2=C1 QTQWMSOQOSJFBV-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Landscapes
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310376093.3A CN103396360B (zh) | 2013-08-26 | 2013-08-26 | 一种制备磷酸伯胺喹的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310376093.3A CN103396360B (zh) | 2013-08-26 | 2013-08-26 | 一种制备磷酸伯胺喹的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103396360A true CN103396360A (zh) | 2013-11-20 |
CN103396360B CN103396360B (zh) | 2015-08-19 |
Family
ID=49560140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310376093.3A Active CN103396360B (zh) | 2013-08-26 | 2013-08-26 | 一种制备磷酸伯胺喹的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103396360B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB695159A (en) * | 1950-06-08 | 1953-08-05 | Robert Cooley Elderfield | A process for the preparation and manufacture of 6-methoxy-8-alkylene-diamino-quinoline |
US4980360A (en) * | 1990-03-13 | 1990-12-25 | Calspan Corporation | 5-(phenylalkoxy)primaquine compounds and their use for treatment of malaria |
US5104885A (en) * | 1990-03-13 | 1992-04-14 | Calspan Corporation | 5-(phenylalkoxy)primaquine and 5[(heterocycle)alkoxy] primaquine compounds and their use for treatment of malaria |
CN1220988A (zh) * | 1997-12-24 | 1999-06-30 | 南京大学 | 无溶剂合成席夫碱的方法 |
CN101781230A (zh) * | 2009-01-16 | 2010-07-21 | 中国中化集团公司 | 一种催化脱水合成亚胺的方法 |
-
2013
- 2013-08-26 CN CN201310376093.3A patent/CN103396360B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB695159A (en) * | 1950-06-08 | 1953-08-05 | Robert Cooley Elderfield | A process for the preparation and manufacture of 6-methoxy-8-alkylene-diamino-quinoline |
US4980360A (en) * | 1990-03-13 | 1990-12-25 | Calspan Corporation | 5-(phenylalkoxy)primaquine compounds and their use for treatment of malaria |
US5104885A (en) * | 1990-03-13 | 1992-04-14 | Calspan Corporation | 5-(phenylalkoxy)primaquine and 5[(heterocycle)alkoxy] primaquine compounds and their use for treatment of malaria |
CN1220988A (zh) * | 1997-12-24 | 1999-06-30 | 南京大学 | 无溶剂合成席夫碱的方法 |
CN101781230A (zh) * | 2009-01-16 | 2010-07-21 | 中国中化集团公司 | 一种催化脱水合成亚胺的方法 |
Non-Patent Citations (3)
Title |
---|
DAVID E.等: "Michael Additions of Nitroalkanes to α,β-Unsaturated Carbonyl Compounds Using KF/Basic Alumina", 《J. ORG. CHEM.》, vol. 52, no. 8, 1 April 1987 (1987-04-01), pages 1601 - 1603 * |
姚其正: "《药物合成反应》", 30 September 2012, 中国医药科技出版社, article "亚胺的还原", pages: 446-448 * |
梁剑生: "《有机化学》", 31 December 1979, 化学工业出版社, article "氨基的反应", pages: 192 * |
Also Published As
Publication number | Publication date |
---|---|
CN103396360B (zh) | 2015-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2262756B1 (en) | Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates | |
EP2602250B1 (en) | Method for preparing rosuvastatin calcium intermediate | |
EP2755959B1 (en) | Rilpivirine hydrochloride | |
CN106365986B (zh) | 化合物及其制备方法和在合成布瓦西坦中的用途 | |
EP2621909B1 (en) | Process for preparing bosentan monohydrate and its intermediates | |
EP2301909A1 (en) | Processes for preparing pemetrexed disodium and its intermediate,4-(4-carbomethoxyphenyl)butanal | |
CN113979993A (zh) | 一种不对称合成(s)-烟碱的方法 | |
DK3250556T3 (en) | PROCEDURES FOR THE PREPARATION OF COMPOUNDS, SUCH AS 3-ARYL BUTANALS THAT CAN BE USED FOR THE SYNTHESIS OF MEDETOMIDINE | |
WO2011086570A1 (en) | Process for preparation of cyanoalkylpropionate derivatives | |
CN103396360B (zh) | 一种制备磷酸伯胺喹的方法 | |
CN101735080A (zh) | 反式4-氨基-1-金刚烷醇盐酸盐合成工艺 | |
EP2547663A1 (en) | A process for the preparation of highly pure ambrisentan | |
EP2307373A1 (en) | A process for preparing atovaquone and associate intermediates | |
CA3136883A1 (en) | Process for the preparation of fungicidally active strobilurin compounds and intermediates thereof | |
CN110627752B (zh) | 一种3-氨甲基四氢呋喃的制备方法 | |
CN101671267B (zh) | 一种直接将醛或脂肪族甲基酮的亚硫酸氢钠加成产物转变为相应肟的方法 | |
CN104529908A (zh) | 一种瑞舒伐他汀钙的制备方法 | |
CN103772308B (zh) | 5-氨基-3-(1-乙基-1-甲基丙基)异噁唑中间体的制备方法和异噁草胺的制备方法 | |
CN110294768B (zh) | 一种通过2,6-二乙基-4-甲基苯丙二酸酯合成唑啉草酯的方法 | |
CN103958467B (zh) | 制备6-氯-2,3,4,9-四氢-1h-咔唑-1-甲酰胺及其前体的方法 | |
WO2017149017A1 (en) | Method for preparation of hydroxytyrosol | |
CN114213323B (zh) | 一种盐酸丙卡特罗的合成新工艺 | |
CN106083624B (zh) | 3-氨基-3-苯基丙酸酯的一锅法合成工艺 | |
CN106699626B (zh) | 一种2-羟基-3-甲氧基-3,3-二苯基丙酸盐消旋体的制备方法 | |
JPH0841005A (ja) | 4−フルオルアルコキシシンナモニトリル類の製法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200317 Address after: Room 1202, floor 12, Tianyi Chuangye building, west side of Yangliu, Yisuhe Town, Xiangtan County, Xiangtan City, Hunan Province Patentee after: Hunan Furui Biomedical Technology Co.,Ltd. Address before: 200237 Meilong Road, Shanghai, No. 130, No. Patentee before: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for preparing primary aminoquine phosphate Granted publication date: 20150819 Pledgee: Agricultural Bank of China Xiangtan County Branch Pledgor: Hunan Furui Biomedical Technology Co.,Ltd. Registration number: Y2024980000042 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |